Prospective, observational international cohort study.~Any hospital worldwide can participate (including hospitals that have not admitted SARS-CoV-2 infected patients).~All patients undergoing a surgical procedure in an operating theatre will be included. All consecutive eligible patients should be included.~7-day data collection period, with follow-up at 30 days after surgery for each patient. However, no changes should be made to normal patient care/ follow-up pathways~Primary outcome is 30-day mortality.~All collaborators will be included as PubMed-citable co-authors on resulting publications.
Observational study to determine the optimal timing for surgery following SARS-CoV-2 infection and assess key global surgery indicators.